CYP2D6 genotype predicts tamoxifen discontinuation and drug response: a secondary analysis of the KARISMA trial

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-advertisement	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Analytics" category .
cookielawinfo-checkbox-functional	1 year	The cookie is set by the GDPR Cookie Consent plugin to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Necessary" category .
cookielawinfo-checkbox-others	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Others".
cookielawinfo-checkbox-performance	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Performance".
CookieLawInfoConsent	1 year	Records the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
viewed_cookie_policy	1 year	The cookie is set by the GDPR Cookie Consent plugin to store whether or not the user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.

Cookie	Duration	Description
_ga	2 years	The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_ga_*	1 year 1 month 4 days	Google Analytics sets this cookie to store and count page views.
_gat_gtag_UA_*	1 minute	Set by Google to distinguish users.
_gat_gtag_UA_130158745_1	1 minute	Set by Google to distinguish users.
_gid	1 day	Installed by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.

Others

Karolinska Mammography Project
for Risk Prediction of Breast Cancer

The KARMA study is supported by the Märit and Hans Rausing Initiative Against Breast Cancer, the Swedish Research Council, the Swedish Cancer Society, the Kamprad Foundation, and Stockholm County Council.

Karolinska Mammography Project
for Risk Prediction of Breast Cancer

The KARMA study is supported by the Märit and Hans Rausing Initiative Against Breast Cancer, the Swedish Research Council, the Swedish Cancer Society, the Kamprad Foundation, and Stockholm County Council.

2021

CYP2D6 genotype predicts tamoxifen discontinuation and drug response: a secondary analysis of the KARISMA trial

Karolinska Mammography Project for Risk Prediction of Breast Cancer

The KARMA study is supported by the Märit and Hans Rausing Initiative Against Breast Cancer, the Swedish Research Council, the Swedish Cancer Society, the Kamprad Foundation, and Stockholm County Council.

Karolinska Mammography Projectfor Risk Prediction of Breast Cancer

The KARMA study is supported by the Märit and Hans Rausing Initiative Against Breast Cancer, the Swedish Research Council, the Swedish Cancer Society, the Kamprad Foundation, and Stockholm County Council.

2021

CYP2D6 genotype predicts tamoxifen discontinuation and drug response: a secondary analysis of the KARISMA trial

Karolinska Mammography Project
for Risk Prediction of Breast Cancer

Karolinska Mammography Project
for Risk Prediction of Breast Cancer